DHR — DANAHER CORP /DE/

NYSE · Unknown · Unknown · CIK 313616 ·
Last close
$178.97
Market Cap
$126.67B
52W High
$200.50
52W Low
$160.93
ADV30
4,386,452
Next earnings
2026-07-21
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 5,951,000,000 3,591,000,000 1,344,000,000 1,029,000,000 83,544,000,000 5,701,000,000 30,587,000,000
Dec 2025 6,838,000,000 3,966,000,000 1,502,000,000 1,197,000,000 83,464,000,000 4,615,000,000 30,923,000,000
Sep 2025 6,053,000,000 3,523,000,000 1,154,000,000 908,000,000 79,897,000,000 1,528,000,000 28,817,000,000
Jun 2025 5,936,000,000 3,523,000,000 760,000,000 555,000,000 81,620,000,000 2,957,000,000 29,278,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$6,439,000,000
Investing CF
$-1,203,000,000
Financing CF
$-1,660,000,000
CapEx
$-1,148,000,000
Dividends Paid
$-910,000,000
Buybacks
$-2,010,000,000
EPS Diluted TTM
$5.17
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$47,637,000,000
Inventory
$2,608,000,000
Receivables
$3,819,000,000
ST Investments
EBIT TTM
$4,595,000,000
Pretax Income TTM
$4,339,000,000
Interest Exp TTM
$256,000,000
Analysts
22

Yahoo Snapshot (yfinance, live)

Total Revenue
$24,778,000,384
EBITDA
$7,935,000,064
Free Cash Flow
$4,568,500,224
Enterprise Value
$140,660,703,232
Total Cash
$5,701,000,192
Total Debt
$19,683,999,744
Shares Out
707,770,627
Trailing EPS
$5.15
Book Value
$74.82
ROE
7.1%
ROA
4.2%
Div Yield
0.89%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 24,568,000,000 4,690,000,000 3,614,000,000 83,464,000,000 30,923,000,000 6,416,000,000
Dec 2024 23,875,000,000 4,863,000,000 3,899,000,000 77,542,000,000 27,992,000,000 6,688,000,000
Dec 2023 23,890,000,000 5,202,000,000 4,764,000,000 84,488,000,000 30,998,000,000 7,164,000,000
Dec 2022 26,643,000,000 7,536,000,000 7,209,000,000 84,350,000,000 34,260,000,000 8,519,000,000

TTM Snapshot

Revenues TTM
$26,314,000,000
NetIncome TTM
$4,677,000,000
OpCashFlow TTM
$0
Assets (Latest)
$77,542,000,000
Forward EPS
$9.21

Max Pain — expiry 2026-07-17

max pain strike: $175.00 · spot: $188.04 · call oi: 12,265 · put oi: 4,652
Expected Move to 2026-07-17: ±$12.45 (6.62%) — implied range $175.59$200.49 · ATM straddle on $190.00 strike

News headlines (Yahoo Finance, 1h cache)

Danaher Is Down 22% This Year. Is the Masimo Acquisition the Entry Point Investors Have Been Waiting for?
2026-06-24 17:55 · Yahoo
HSBC Cuts PT on Danaher Corporation (DHR) – Here’s Why
2026-06-24 12:14 · Yahoo
VTRS vs. DHR: Which Stock Is the Better Value Option?
2026-06-23 15:40 · Yahoo
1 Profitable Stock with Promising Prospects and 2 That Underwhelm
2026-06-23 07:52 · Yahoo
Is AMETEK Stock Just More Market Exposure?
2026-06-22 20:21 · Yahoo
Danaher Schedules Second Quarter 2026 Earnings Conference Call
2026-06-22 20:15 · Yahoo
Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner
2026-06-22 12:00 · Yahoo
Global Automated Liquid Handling Systems Market Size/Share Worth USD 6.9 Billion by 2035 at a 9.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Grow
2026-06-19 02:30 · Yahoo
Medtech M&A maintains momentum following decade-high 2025: PwC
2026-06-17 11:00 · Yahoo
Analysts' Top S&P 500 Stocks to Buy Now
2026-06-16 20:57 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.